ArticleMolecular cancer2023

Durable response of lung carcinoma patients to EGFR tyrosine kinase inhibitors is determined by germline polymorphisms in some immune-related genes.

Lorraine Dalens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.